McMaster Childrens Hospital

Hamilton, Ontario L8S4K1

4 studies enrolling now · 28 studies all time

What they study most

Acute Kidney Injury, Acute Lymphoblastic Leukemia, Anthracycline-induced Cardiotoxicity, Apnea Neonatal, COVID, Candidiasis, Cardiac Disease, Childhood Solid Tumor, Crohn's Disease, Deep Vein Thrombosis, Deep Vein Thrombosis (DVT), Ependymoma, Recurrent Childhood

Studies at this site

• Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates — Recruiting now
• TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II — Recruiting now
• Stress Hydrocortisone In Pediatric Septic Shock — Recruiting now
• Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis — Recruiting now
• A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors — Running, not enrolling
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors — Completed
• Evaluation of the Duration of Therapy for Thrombosis in Children — Completed
• Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B — Completed
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) — Completed
• A Study of ALS-008176 in Infants Hospitalized With RSV — Completed
• COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors — Completed
• Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG) — Running, not enrolling
• An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) — Completed
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study — Completed
• Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease — Completed
• A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study) — Completed
• Pediatric Acute Kidney Injury in COVID-19 — Completed
• Alphanate in Immune Tolerance Induction Therapy — Stopped early
• Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients — Completed
• Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII — Completed
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Completed
• ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP — Completed
• A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus — Stopped early
• Preventing Cardiac Sequelae in Pediatric Cancer Survivors — Completed
• Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children — Completed
• Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis — Stopped early
• Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A — Status unconfirmed